Literature DB >> 30872264

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.

Hagma H Workel1, Joyce M Lubbers1, Roland Arnold2, Thalina M Prins1, Pieter van der Vlies3, Kim de Lange3, Tjalling Bosse4, Inge C van Gool4, Florine A Eggink1, Maartje C A Wouters5, Fenne L Komdeur1, Elisabeth C van der Slikke1, Carien L Creutzberg6, Arjan Kol1, Annechien Plat1, Mark Glaire7, David N Church7,8, Hans W Nijman1, Marco de Bruyn9.   

Abstract

The chemokine CXCL13 mediates recruitment of B cells to tumors and is essential for the formation of tertiary lymphoid structures (TLSs). TLSs are thought to support antitumor immunity and are associated with improved prognosis. However, it remains unknown whether TLSs are formed in response to the general inflammatory character of the tumor microenvironment, or rather, are induced by (neo)antigen-specific adaptive immunity. We here report on the finding that the TGFβ-dependent CD103+CD8+ tumor-infiltrating T-cell (TIL) subpopulation expressed and produced CXCL13. Accordingly, CD8+ T cells from peripheral blood activated in the presence of TGFβ upregulated CD103 and secreted CXCL13. Conversely, inhibition of TGFβ receptor signaling abrogated CXCL13 production. CXCL13+CD103+CD8+ TILs correlated with B-cell recruitment, TLSs, and neoantigen burden in six cohorts of human tumors. Altogether, our findings indicated that TGFβ plays a noncanonical role in coordinating immune responses against human tumors and suggest a potential role for CXCL13+CD103+CD8+ TILs in mediating B-cell recruitment and TLS formation in human tumors. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 30872264     DOI: 10.1158/2326-6066.CIR-18-0517

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  50 in total

1.  Breaking barriers for T cells by targeting the EPHA2/TGF-β/COX-2 axis in pancreatic cancer.

Authors:  Jose R Conejo-Garcia
Journal:  J Clin Invest       Date:  2019-07-29       Impact factor: 14.808

2.  Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.

Authors:  Grégory Noël; Mireille Langouo Fontsa; Soizic Garaud; Pushpamali De Silva; Alexandre de Wind; Gert G Van den Eynden; Roberto Salgado; Anaïs Boisson; Hanne Locy; Noémie Thomas; Cinzia Solinas; Edoardo Migliori; Céline Naveaux; Hugues Duvillier; Sophie Lucas; Ligia Craciun; Kris Thielemans; Denis Larsimont; Karen Willard-Gallo
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 14.808

Review 3.  Cell and tissue engineering in lymph nodes for cancer immunotherapy.

Authors:  Alexander J Najibi; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2020-08-01       Impact factor: 15.470

Review 4.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

Review 5.  Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.

Authors:  Marta Trüb; Alfred Zippelius
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 6.  T peripheral helper cells in autoimmune diseases.

Authors:  Kathryne E Marks; Deepak A Rao
Journal:  Immunol Rev       Date:  2022-02-01       Impact factor: 12.988

7.  Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy.

Authors:  Julie Niogret; Hélène Berger; Cédric Rebe; Frederique Vegran; Francois Ghiringhelli; Fanny Chalmin; Romain Mary; Elise Ballot; Caroline Truntzer; Marion Thibaudin; Valentin Derangère; Christophe Hibos; Léa Hampe; David Rageot; Théo Accogli; Philippe Joubert; Bertrand Routy; James Harker
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

8.  Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients.

Authors:  S T Paijens; A Vledder; D Loiero; E W Duiker; J Bart; A M Hendriks; M Jalving; H H Workel; H Hollema; N Werner; A Plat; G B A Wisman; R Yigit; H Arts; A J Kruse; N M de Lange; V H Koelzer; M de Bruyn; H W Nijman
Journal:  Oncoimmunology       Date:  2021-06-06       Impact factor: 8.110

9.  PD-1+CXCR5-CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma.

Authors:  Jiang-Ping Li; Chang-You Wu; Ming-Yuan Chen; Shang-Xin Liu; Shu-Mei Yan; Yin-Feng Kang; Cong Sun; Jennifer R Grandis; Mu-Sheng Zeng; Qian Zhong
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

Review 10.  Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.

Authors:  Hye-Won Lee
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.